Danimer Scientific Inc
NYSE:DNMR
Danimer Scientific Inc
NYSE:DNMR
Price:
0.35
USD
Market Closed
Market Cap:
$60k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Danimer Scientific Inc
NYSE:DNMR
|
US |
|
Zotye Automobile Co Ltd
SZSE:000980
|
CN |
|
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
|
CN |
Income Statement
Earnings Waterfall
Danimer Scientific Inc
Danimer Scientific Inc
Income Statement
Danimer Scientific Inc
Danimer Scientific Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
2
|
3
|
3
|
3
|
1
|
2
|
2
|
2
|
2
|
5
|
13
|
21
|
30
|
35
|
35
|
36
|
|
| Revenue |
47
N/A
|
61
+28%
|
75
+24%
|
88
+18%
|
59
-34%
|
60
+3%
|
59
-3%
|
56
-5%
|
53
-4%
|
50
-5%
|
51
+0%
|
51
+1%
|
47
-9%
|
45
-4%
|
40
-12%
|
37
-6%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(34)
|
(47)
|
(59)
|
(72)
|
(56)
|
(60)
|
(61)
|
(61)
|
(61)
|
(64)
|
(70)
|
(76)
|
(71)
|
(69)
|
(64)
|
(61)
|
|
| Gross Profit |
13
N/A
|
13
+5%
|
16
+16%
|
16
+3%
|
3
-83%
|
0
-96%
|
(2)
N/A
|
(5)
-116%
|
(8)
-57%
|
(14)
-78%
|
(20)
-39%
|
(24)
-25%
|
(24)
+0%
|
(24)
+1%
|
(24)
-1%
|
(24)
+2%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(29)
|
(40)
|
(63)
|
(96)
|
(102)
|
(119)
|
(128)
|
(124)
|
(116)
|
(111)
|
(105)
|
(100)
|
(101)
|
(87)
|
(75)
|
(63)
|
|
| Selling, General & Administrative |
(20)
|
(30)
|
(49)
|
(76)
|
(81)
|
(93)
|
(97)
|
(91)
|
(82)
|
(80)
|
(75)
|
(71)
|
(70)
|
(59)
|
(49)
|
(39)
|
|
| Research & Development |
(8)
|
(10)
|
(14)
|
(18)
|
(17)
|
(20)
|
(25)
|
(28)
|
(26)
|
(24)
|
(22)
|
(19)
|
(21)
|
(22)
|
(19)
|
(17)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(2)
|
(4)
|
(5)
|
(6)
|
(6)
|
(8)
|
(10)
|
(11)
|
(13)
|
(9)
|
(7)
|
(7)
|
(7)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(16)
N/A
|
(27)
-72%
|
(48)
-77%
|
(80)
-66%
|
(99)
-25%
|
(119)
-20%
|
(130)
-9%
|
(129)
+0%
|
(124)
+4%
|
(125)
-1%
|
(124)
+1%
|
(124)
+0%
|
(125)
-1%
|
(112)
+11%
|
(99)
+11%
|
(87)
+13%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
2
|
(79)
|
(21)
|
7
|
27
|
112
|
55
|
28
|
8
|
(1)
|
(10)
|
(20)
|
(29)
|
(34)
|
(29)
|
(30)
|
|
| Non-Reccuring Items |
5
|
3
|
4
|
4
|
(1)
|
2
|
(0)
|
(65)
|
(65)
|
(65)
|
(65)
|
(0)
|
(1)
|
(0)
|
(1)
|
6
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(9)
N/A
|
(104)
-1 071%
|
(64)
+38%
|
(68)
-5%
|
(73)
-8%
|
(5)
+93%
|
(75)
-1 322%
|
(167)
-122%
|
(181)
-8%
|
(191)
-6%
|
(199)
-5%
|
(144)
+28%
|
(155)
-8%
|
(146)
+6%
|
(129)
+11%
|
(111)
+14%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
11
|
13
|
14
|
14
|
3
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(9)
|
(104)
|
(64)
|
(56)
|
(60)
|
8
|
(61)
|
(164)
|
(180)
|
(190)
|
(199)
|
(144)
|
(155)
|
(146)
|
(130)
|
(111)
|
|
| Net Income (Common) |
(9)
N/A
|
(104)
-1 071%
|
(64)
+38%
|
(56)
+12%
|
(60)
-7%
|
8
N/A
|
(61)
N/A
|
(164)
-167%
|
(180)
-9%
|
(190)
-6%
|
(199)
-5%
|
(144)
+28%
|
(155)
-8%
|
(146)
+6%
|
(130)
+11%
|
(111)
+14%
|
|
| EPS (Diluted) |
-0.1
N/A
|
-1.23
-1 130%
|
-0.63
+49%
|
-0.54
+14%
|
-0.65
-20%
|
0.09
N/A
|
-0.6
N/A
|
-1.62
-170%
|
-1.78
-10%
|
-1.88
-6%
|
-1.96
-4%
|
-1.41
+28%
|
-60.97
-4 224%
|
-55.73
+9%
|
-43.43
+22%
|
-37.15
+14%
|
|
Switch to:
Switch to:
See Also
Discover More
